Compare Nortech Systems, Inc. with Similar Stocks
Dashboard
Poor Management Efficiency with a low ROCE of 8.91%
- The company has been able to generate a Return on Capital Employed (avg) of 8.91% signifying low profitability per unit of total capital (equity and debt)
Poor long term growth as Net Sales has grown by an annual rate of 0.49% over the last 5 years
The company has declared Negative results for the last 4 consecutive quarters
Risky - Negative EBITDA
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
USD 23 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.37
-6.17%
0.70
Total Returns (Price + Dividend) 
Nortech Systems, Inc. for the last several years.
Risk Adjusted Returns v/s 
News

Nortech Systems, Inc. Experiences Revision in Its Stock Evaluation Amid Financial Challenges
Nortech Systems, Inc. reported a challenging quarter ending June 2025, with a decline in net profit and net sales. Despite achieving its highest operating profit and a reduction in raw material costs, the company faces increased financial leverage and negative operating cash flow, alongside significant stock performance issues.
Read full news article
Nortech Systems Hits New 52-Week Low at $6.50 Amid Ongoing Struggles
Nortech Systems, Inc. has reached a new 52-week low, reflecting a significant decline in performance over the past year. The company faces financial challenges, including negative returns and stagnant sales growth, while reporting losses for four consecutive quarters. Its market position raises concerns about long-term viability in the biotechnology sector.
Read full news article Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 4 Schemes (1.54%)
Held by 2 Foreign Institutions (0.12%)
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
YoY Growth in quarter ended Sep 2025 is -2.87% vs -5.99% in Sep 2024
YoY Growth in quarter ended Sep 2025 is 85.71% vs -158.33% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -8.04% vs 3.88% in Dec 2023
YoY Growth in year ended Dec 2024 is -118.84% vs 245.00% in Dec 2023






